Lexicon Pharmaceuticals, Inc.
(NASDAQ : LXRX)

( )
LXRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Loading LXRX News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.78%71.571.0%$655.39m
AMGNAmgen Inc.
-1.27%153.800.8%$502.42m
CELGCelgene Corporation
-1.39%113.621.0%$465.54m
ARIAARIAD Pharmaceuticals, Inc.
0.02%23.7016.4%$429.03m
BIIBBiogen Inc.
-1.15%280.351.0%$389.15m
REGNRegeneron Pharmaceuticals, Inc.
0.13%363.412.5%$362.46m
ALXNAlexion Pharmaceuticals, Inc.
-1.12%134.352.5%$359.12m
ILMNIllumina, Inc.
-0.40%160.583.8%$225.19m
CLVSClovis Oncology, Inc.
0.87%57.1117.9%$163.62m
INCYIncyte Corporation
2.12%117.532.2%$153.09m
VRTXVertex Pharmaceuticals Incorporated
-1.95%80.912.1%$150.84m
TSROTESARO, Inc.
0.44%149.9115.0%$106.95m
SRPTSarepta Therapeutics, Inc.
-4.86%34.2316.8%$106.34m
IONSIonis Pharmaceuticals, Inc.
-0.93%46.708.9%$103.74m
BMRNBioMarin Pharmaceutical Inc.
-1.16%86.154.9%$100.55m

Company Profile

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company, focuses on the development of breakthrough treatments for human disease. It has multiple programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications. Lexicon Pharmaceuticals was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.